ID   UACC-1179
AC   CVCL_4036
SY   UACC 1179; UACC1179; University of Arizona Cell Culture-1179
DR   ATCC; CRL-3127
DR   Wikidata; Q54973797
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=7842014;
RX   PubMed=9778046;
RX   PubMed=15153330;
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive (ATCC=CRL-3127).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (ATCC=CRL-3127).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3127
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 20
ST   D19S433: 13.2,16.2
ST   D21S11: 31
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 27
ST   Penta D: 11
ST   Penta E: 13,17
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz A.;
RT   "Cell lines from human breast.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994).
//
RX   PubMed=7842014; DOI=10.1038/ng1094-155;
RA   Guan X.-Y., Meltzer P.S., Dalton W.S., Trent J.M.;
RT   "Identification of cryptic sites of DNA sequence amplification in
RT   human breast cancer by chromosome microdissection.";
RL   Nat. Genet. 8:155-161(1994).
//
RX   PubMed=9778046; DOI=10.1038/sj.onc.1202086;
RA   Rice J.C., Massey-Brown K.S., Futscher B.W.;
RT   "Aberrant methylation of the BRCA1 CpG island promoter is associated
RT   with decreased BRCA1 mRNA in sporadic breast cancer cells.";
RL   Oncogene 17:1807-1812(1998).
//
RX   PubMed=15153330; DOI=10.1593/neo.3292;
RA   Watts G.S., Oshiro M.M., Junk D.J., Wozniak R.J., Watterson S.J.,
RA   Domann F.E., Futscher B.W.;
RT   "The acetyltransferase p300/CBP-associated factor is a p53 target gene
RT   in breast tumor cells.";
RL   Neoplasia 6:187-194(2004).
//